Aktie - AKN | ADVFN

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

Gebot

Fragen

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

American Stock Exchange Lists Safety First Trust Series 2007-4 Principal-Protected Trust Certificates Linked to a Global Index B

NEW YORK, Nov. 23 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) opened trading today on Safety First Trust Series 2007-4...

Akorn, Inc. Signs an Exclusive Supply Agreement For Hydase(TM) (Hyaluronidase Injection, USP) 150 Units/mL, an NDA Product

Akorn, Inc. (AMEX: AKN) today announced that it has signed an Exclusive Supply Agreement with PrimaPharm, Inc., a privately-held...

Akorn, Inc. Announces Move to Nasdaq Global Market

Akorn, Inc. (AMEX:AKN) today announced that its common stock listing application for the Nasdaq Global Market (Nasdaq) has been...

Akorn, Inc. Announces Positive Phase III Pivotal Trial Results for Akten(R)

Akorn, Inc. (AMEX: AKN) today announced the positive results of a Phase III pivotal trial for Akten?. The clinical trial was a...

Akorn, Inc. Signs Exclusive Definitive Agreement For the Development and Supply of Three Ophthalmic ANDA Drug Products

Akorn, Inc. (AMEX: AKN) today announced that it has signed a Definitive Agreement with Azad Pharma, a privately-held...

Akorn, Inc. and Strides Arcolab Limited Agree to Expand the Akorn-Strides, LLC Joint Venture Product Pipeline to Twenty-Nine AND

Akorn, Inc. (AMEX: AKN) and Strides Arcolab Limited (NSE: STAR, BSE: 532531) today announced that both Companies have agreed to...

Akorn, Inc. and Serum Institute of India, Ltd. Announce the Signing of a Definitive Development and Exclusive Distribution Agree

Akorn, Inc. (AMEX:AKN) and Serum Institute of India, Ltd. today announced that they have entered into a Definitive Development...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

AKN - Frequently Asked Questions (FAQ)

What is the current share price?

The current share price of is US$ 0,00

What is the 1 year trading range for share price?

has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
FLAGGlobal X S&P 500 US Market Leaders Top 50 ETF	US$ 24,69 (208,63%)	1,46k
BTTRBetter Choice Company Inc	US$ 2,025 (46,20%)	315,77k
CHROChannel Therapeutics Corporation	US$ 1,76 (40,24%)	39,55M
LLYXDefiance Daily Target 2X Long LLY ETF	US$ 19,57 (28,50%)	881,26k
DJTUT REX 2X Long DJT Daily Target ETF	US$ 19,17 (24,36%)	85,52k
FOXOFOXO Technologies Inc	US$ 0,0841 (-22,84%)	1,65M
NVOXDefiance Daily Target 2x Long Nvo ETF	US$ 4,82 (-15,69%)	282,82k
AZTRAzitra Inc	US$ 0,28 (-11,95%)	381,57k
PTNPalatin Technologies Inc New	US$ 0,217001 (-11,79%)	13,11M
TOPPToppoint Holdings Inc	US$ 1,08 (-11,48%)	6,36k
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 9,20 (-1,50%)	233,53M
SPXSDirexion Daily S&P 500 Bear 3X Shares New	US$ 7,7151 (-0,06%)	83,14M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	US$ 3,66 (0,14%)	78,82M
SPYSPDR S&P 500	US$ 526,41 (0,14%)	78,53M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF	US$ 3,57 (6,09%)	69,89M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AKN)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

AKN Neueste Nachrichten

American Stock Exchange Lists Safety First Trust Series 2007-4 Principal-Protected Trust Certificates Linked to a Global Index B

Akorn, Inc. Signs an Exclusive Supply Agreement For Hydase(TM) (Hyaluronidase Injection, USP) 150 Units/mL, an NDA Product

Akorn, Inc. Announces Move to Nasdaq Global Market

Akorn, Inc. Announces Positive Phase III Pivotal Trial Results for Akten(R)

Akorn, Inc. Signs Exclusive Definitive Agreement For the Development and Supply of Three Ophthalmic ANDA Drug Products

Akorn, Inc. and Strides Arcolab Limited Agree to Expand the Akorn-Strides, LLC Joint Venture Product Pipeline to Twenty-Nine AND

Akorn, Inc. and Serum Institute of India, Ltd. Announce the Signing of a Definitive Development and Exclusive Distribution Agree

Akorn, Inc. and Natco Pharma Limited Add Two Injectable Drug Products To API Supply and Margin Sharing Agreement

Akorn, Inc. Reports Third Quarter 2006 Revenues of $14.5 million and 41% Gross Margin

Akorn, Inc. Announces Third Quarter 2006 Earnings Release and Conference Call Information

AKN - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AKN) Börsenkurse

Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AKN)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

AKN Neueste Nachrichten

American Stock Exchange Lists Safety First Trust Series 2007-4 Principal-Protected Trust Certificates Linked to a Global Index B

Akorn, Inc. Signs an Exclusive Supply Agreement For Hydase(TM) (Hyaluronidase Injection, USP) 150 Units/mL, an NDA Product

Akorn, Inc. Announces Move to Nasdaq Global Market

Akorn, Inc. Announces Positive Phase III Pivotal Trial Results for Akten(R)

Akorn, Inc. Signs Exclusive Definitive Agreement For the Development and Supply of Three Ophthalmic ANDA Drug Products

Akorn, Inc. and Strides Arcolab Limited Agree to Expand the Akorn-Strides, LLC Joint Venture Product Pipeline to Twenty-Nine AND

Akorn, Inc. and Serum Institute of India, Ltd. Announce the Signing of a Definitive Development and Exclusive Distribution Agree

Akorn, Inc. and Natco Pharma Limited Add Two Injectable Drug Products To API Supply and Margin Sharing Agreement

Akorn, Inc. Reports Third Quarter 2006 Revenues of $14.5 million and 41% Gross Margin

Akorn, Inc. Announces Third Quarter 2006 Earnings Release and Conference Call Information

AKN - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE